The Correlation of the World Health Organization Histologic Classification of Thymic Epithelial Tumors and Its Prognosis: A Clinicopathologic Study of 108 Patients From China

Abstract

This study retrospectively reviewed the clinicopathological features of thymic epithelial tumors in 108 patients, and evaluated World Health Organization (WHO) histologic classification of thymic tumors. Other prognostic factors, including age, gender, clinical stage, and completeness of tumor resection were also analyzed. Seven type A tumors, 19 type AB, 23 type B1, 19 type B2, 27 type B3, and 13 thymic carcinomas were studied. The 5-year and 10-year survival rates were 100% after resection of tumor types A and AB; 93% and 81% for B1; 83% and 70% for B2; and 43% and 33% for B3. The overall 5-year and 10-year survival rates were 72.0% and 63.0%, respectively. Tumor classification was highly significant in predicting survival (P .001) and also reflected the clinical behavior of tumors. The Masaoka stage was the most important independent prognostic index in thymomas. The WHO histologic subtype and completeness of resection were also important prognostic factors.

Keywords

Masaoka clinical stage pathology surgery thymoma prognosis WHO histologic subtype

Get full access to this article

View all access options for this article.

References

Pescarmona E. , Rendina EA , Venuta F. , et al. Analysis of prognostic factors and clinicopathological staging of thymoma. Ann Thorac Surg. 1990;50:534-538.

Quintanilla-Martinez L. , Wilkiins EW Jr , Choi N. , Efird J. , Hug E. , Harris NL Thymoma histologic subclassification is an independent prognostic factor. Cancer . 1994 ;74: 606-617.

Schneider PM , Fellbaum C. , Fink U. , Bollschweiler E. , Präuer HW Prognostic importance of histomorphologic subclassification for epithelial thymic tumors. Ann Surg Oncol . 1997;4:46-56.

Okumura M. , Miyoshi S. , Takeuchi Y. , et al. Results of surgical treatment of thymomas with special reference to the involved organs. J Thorac Cardiovacs Surg. 1999;117: 605-613.

Nakagawa K. , Asamura H. , Matsuno Y. , et al. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg. 2003;126:1134-1140.

Rosai J. , Sobin LH World Health Organization Histological Classification of Tumours. Histological Typing of Tumours of the Thymus. 2nd ed. Berlin, Germany: Springer-Verlag ; 1999.

Okumura M. , Shiono H. , Minami M. , et al. Clinical and pathological aspects of thymic epithelial tumors . Gen Thorac Cardiovasc Surg. 2008;56:10-16.

Chalabreysse L. , Roy P. , Cordier JF , Loir R. , Gamondes JP , Thivolet-Bejui F. Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: a retrospective study of 90 tumors. Am J Surg Pathol . 2002;26:1605-1611.

Kondo K. , Yoshizawa K. , Tsuyuguchi M. , et al. WHO histologic classification is a prognostic indicator in thymoma . Ann Thorac Surg. 2004;77:1183-1188.

10.

Wright CD , Wain JC , Wong DR , et al. Predictors of recurrence in thymic tumors: importance of invasion, World Health Organization histology, and size. J Thorac Cardiovasc Surg. 2005;130:1413-1421.

11.

Masaoka A. , Monden Y. , Nakahara K. , Tanioka T. Follow-up study of thymoma with special reference to their clinical stages . Cancer. 1981;48:2485-2492.

12.

Chen G. , Marx A. , Wen-Hu C. , et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China . Cancer. 2002;95:420-429.

13.

Kim DJ , Yang WI , Choi SS , Kim KD , Chung KY Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors. Chest . 2005;127:755-761.

14.

Rena O. , Papalia E. , Maggi G. , et al. World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer. 2005:50:59-66.

15.

Park MS , Chung KY , Kim KD , et al. Prognosis of thymic epithelial tumors according to the New WHO histologic classification. Ann Thorac Surg. 2004,78:992-997.

16.

Horinouchi H. , Asakura K. , Kimura Y. , et al. Prognosis of surgically treated thymic epithelial tumors. Nippon Geka Gakkai Zasshi. 2006;107:262-267.

17.

Okumura M. , Ohta M. , Tateyama H. , et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients . Cancer. 2002;94:624-632.

18.

Okmura M. , Shiono H. , Inoue M. , et al. Outcome of surgical treatment for recurrent thymic epithelial tumors with reference to World Health Organization histologic classification system. J Surg Oncol. 2007;95:40-44.

19.

Kondo K. Optimal therapy for thymoma. J Med Invest. 2008;55:17-28.

20.

Yin HL , Zhang TH , Zhou ZS , et al. Clinical pathological study of resected thymus from 104 myasthenia gravis patients. Chin J Pathol. 1994;23:89-92.